ArticleJournal of experimental & clinical cancer research : CR2023

METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression.

Wei Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.